Company Filing History:
Years Active: 2002
Title: Valérie Jallet: Innovator in Glaucoma Treatment
Introduction
Valérie Jallet is an esteemed inventor based in Meythet, France, who has made significant strides in the field of ophthalmology. With two patents to his name, he has developed innovative solutions aimed at enhancing surgical treatments for glaucoma.
Latest Patents
His latest patents include two groundbreaking inventions:
1. **Sclero-ceratectomy implant for Descemet's membrane** - This invention focuses on a pre-descemetic sclero-keratectomy implant specifically designed to exert pressure on the pre-descemetic plane and the stroma during glaucoma surgery. Made from crosslinked hyaluronic acid, the implant takes on a polyhedron shape with at least five faces, ideally possessing five or six faces. In preferred designs, the implant resembles a prism, often straight with a triangular or rectangular base.
2. **Implant for deep sclerectomy** - This patent pertains to an implant utilized for deep sclerectomy, providing a means of draining aqueous humor during glaucoma operations. Similar to his previous invention, this implant is also made from crosslinked hyaluronic acid and features a polyhedron shape. The ideal embodiment showcases a straight prism with a trapezoidal base.
Career Highlights
Valérie Jallet has been instrumental in developing these innovative implants while working at Corneal Industrie, a company focused on advancing technologies related to corneal health. His contributions to the field of glaucoma treatment position him as a leading figure in medical innovation.
Collaborations
Throughout his career, Valérie has collaborated with noteworthy colleagues such as Philippe Sourdille and Gilles Bos, working together to further enhance solutions for ophthalmological surgical techniques.
Conclusion
Valérie Jallet continues to push the boundaries of invention in the medical field through his pioneering work on glaucoma treatments. With his patented innovations, he plays a crucial role in improving patient outcomes and advancing surgical methodologies.